Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
3.910
-0.020 (-0.51%)
At close: Jun 18, 2026, 4:00 PM EDT
3.920
+0.010 (0.26%)
After-hours: Jun 18, 2026, 7:48 PM EDT
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of $1.75 billion as of June 18, 2026. Its market cap has increased by 185.69% in one year.
Market Cap
1.75B
Enterprise Value
1.48B
1-Year Change
185.69%
Ranking
Category
Stock Price
$3.91
Market Cap Chart
Since February 26, 2015, Iovance Biotherapeutics's market cap has increased from $244.60M to $1.75B, an increase of 613.75%. That is a compound annual growth rate of 18.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.75B | 61.10% |
| Dec 31, 2025 | 1.08B | -51.95% |
| Dec 31, 2024 | 2.26B | 8.40% |
| Dec 29, 2023 | 2.08B | 106.29% |
| Dec 30, 2022 | 1.01B | -66.33% |
| Dec 31, 2021 | 3.00B | -55.99% |
| Dec 31, 2020 | 6.81B | 94.85% |
| Dec 31, 2019 | 3.49B | 220.44% |
| Dec 31, 2018 | 1.09B | 87.59% |
| Dec 29, 2017 | 581.10M | 34.67% |
| Dec 30, 2016 | 431.50M | 16.84% |
| Dec 31, 2015 | 369.30M | 50.98% |
| Feb 26, 2015 | 244.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nurix Therapeutics | 1.81B |
| Rapport Therapeutics | 1.79B |
| Nanobiotix | 1.76B |
| Precigen | 1.72B |
| Recursion Pharmaceuticals | 1.71B |
| Zymeworks | 1.69B |
| AbCellera Biologics | 1.69B |
| Tyra Biosciences | 1.68B |